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SUMMARY
Embryonic stem cells (ESCs) are unique in that they
have the capacity to differentiate into all of the cell
types in the body. We know a lot about the complex
transcriptional control circuits thatmaintain the naive
pluripotent state under self-renewing conditions but
comparatively less about how cells exit from this
state in response to differentiation stimuli. Here, we
examined the role of Otx2 in this process in mouse
ESCs and demonstrate that it plays a leading role in
remodeling the gene regulatory networks as cells
exit from ground state pluripotency. Otx2 drives
enhancer activation through affecting chromatin
marks and the activity of associated genes. Mecha-
nistically, Oct4 is required for Otx2 expression,
and reciprocally, Otx2 is required for efficient Oct4
recruitment to many enhancer regions. Therefore,
the Oct4-Otx2 regulatory axis actively establishes
a new regulatory chromatin landscape during the
early events that accompany exit from ground state
pluripotency.
INTRODUCTION
Embryonic stem cells (ESCs) are capable of generating all of the
different cell types in the body. This unique property, termed
naive pluripotency, is in part determined by their regulatory chro-
matin landscape that allows extracellular signals to trigger the in-
duction of new gene expression programs that direct transition
from this developmental ground state to lineage specification
(reviewed in Nichols and Smith, 2012). Ultimately, this culmi-
nates in the establishment of new stable chromatin states that
define the transcriptional program of differentiated cells (re-
viewed in Young, 2011; Armstrong, 2012). The transcriptional
circuits that enable ESCs to maintain naive pluripotency have
been extensively characterized. These involve a core set of
transcription factors that include the well-studied Nanog, Klf4,
Sox2, and Oct4, but also encompass an increasing number of
other transcriptional and chromatin regulators (reviewed in
Young, 2011). In comparison, less is known about the gene reg-
ulatory mechanisms that drive cells out of the pluripotent ground
state toward commitment to differentiation although several
recent studies have begun to address this issue (Yang et al.,
2012; Davies et al., 2013; Betschinger et al., 2013; Leeb et al.,
2014). One of the first events anticipated to occur during transi-
tion from the ground state is a re-organization of the chromatin
landscape whereby some regulatory regions will be shut down,
and new enhancers will become active. Such regulatory region
switching is commonly observed during cellular differentiation
and development (Nord et al., 2013) and is often driven by pio-
neering factors like FoxA transcription factors (reviewed in Zaret
and Carroll, 2011). However, it is not clear when these events
occur or which factors drive enhancer activation in ESCs. Previ-
ous studies have identified enhancers in ESCs and differentiated
cell types derived from these (Creyghton et al., 2010, Xie et al.,
2013, Gifford et al., 2013), but little attention has been given to
how cells transit between these two states.
Mouse ESCs (mESCs) can bemaintained in definedmedia that
includes two kinase inhibitors (known as ‘‘2i’’) to block the MEK/
ERK and GSK3 signaling pathways (Ying et al., 2008; reviewed
in Wray et al., 2010). Addition of cytokine leukemia inhibitory
factor is not required for self-renewal in 2i; however, its addition
reinforces the ground state through further upregulation of Klf4
and Tcfcp2l1 (Martello et al., 2013). Differentiation can be
induced simply by withdrawing the 2i inhibitors and leukemia
inhibitory factor (Betschinger et al., 2013). We previously con-
ducted a genome-wide siRNA screen in mESCs to identify fac-
tors that regulate exit from ground state pluripotency upon with-
drawal of the 2i inhibitors (Yang et al., 2012).More than 400genes
were identified that are important for this transition, many of
which encode transcriptional or chromatin regulators. One of
these encodes Oct4, which paradoxically is known to be impor-
tant for maintaining pluripotency (reviewed in Young, 2011) and
another encodes the homeodomain transcription factor Otx2.
Otx2 has previously been implicated in development of the
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nervous system and is mutated in patients with brain abnormal-
ities and ocular dysfunction. It also plays an oncogenic role in
medulloblastoma (reviewed in Beby and Lamonerie, 2013).
More recently, consistent with the results from our RNAi screen,
Otx2 was shown to be important for the transition from the em-
bryonic stem cell state to the postimplantation epiblast state
(Acampora et al., 2013). Here we show that Otx2 is one of the
earliest transcription factors whose expression is activated dur-
ing exit from the ground state and that it is involved in early
enhancer activation, in part throughcollaborative functional inter-
actions with Oct4.
RESULTS
Otx2 and Oct4 Bind to Similar Regulatory Regions
To begin to understand how the gene regulatory landscape of
mESCs changes as cells transition from ground state pluripo-
tency, we investigated the potential role for Otx2 in regulatory
region activation during this process. We used chromatin
immunoprecipitation sequencing (ChIP-seq) to monitor the
Otx2 genome-wide binding profile over a 12 hr window following
release of mESCs from culturing in media containing 2i. Otx2
protein expression increases rapidly over this period (Figure S1A;
see also Figure 2D). This increase in expression is accompanied
by increasing numbers of genomic binding regions, culminating
in 1,314 regions after 12 hr (Figure 1A). The majority of the bind-
ing regions exhibit Otx2 occupancy at multiple time points. Gene
ontology analysis revealed that a large proportion of the Otx2
binding regions are associated with genes encoding transcrip-
tional regulators that form a highly interconnected network
(Figure S1B). Many of these transcriptional regulators such as
Jarid2 and Utf1 have been implicated in efficient transition
from pluripotency and subsequent differentiation (Yang et al.,
2012; Pasini et al., 2010a; Kooistra et al., 2010), suggesting
that Otx2 controls an important feed-forward hierarchal regula-
tory network. In this context, Otx2 might sit at the head of
a network of transcriptional regulators that contribute to the
gene expression and phenotypic changes accompanying exit
from ground state pluripotency. Importantly, among the Otx2
targets were 28 genes that we previously identified in a siRNA
screen as playing roles in efficient exit from ground state plurip-
otency (Yang et al., 2012). De novomotif analysis of the 200 base
pairs (bp) surrounding the Otx2 binding summits identified a
sequence centered on a core GGATTA motif as the most signif-
icant hit at all time points and this closely matches the Otx2
consensus binding motif (Figure 1A; Chatelain et al., 2006;
Berger et al., 2008). Importantly, this motif is found in 65% of
the targets at 12 hr, providing evidence for direct binding by
Otx2 and validation of the quality of the ChIP-seq experiment.
In addition to the Otx2 binding motif, we also discovered a motif
that matched the Oct4 consensus binding sequence in the Otx2
binding regions, suggesting potential for cobinding of Otx2 and
Oct4 (Figure 1B). Indeed, interrogation of Oct4 ChIP-seq data
demonstrated that a large proportion of the Otx2 binding regions
are also occupied by Oct4 in mESCs and commonly bound re-
gions contain the Oct4 consensus binding motif (Figures 1C
and S1C). This enabled us to split the data into two categories;
regions bound by Otx2 and Oct4 at one or more time points
(Otx2+/Oct4+) and by Otx2 in the absence of Oct4 binding
(Otx2+/Oct4; Figure S1D). In the Otx2+/Oct4+ subgroup, the
summits of the Otx2 and Oct4 binding peaks are closely juxta-
posed, indicating close association (Figure 1D). However, upon
closer inspection, no composite binding motifs with conserved
spacing were identified, suggesting co-occupancy but without
obligatory direct interactions. Indeed, we were able to demon-
strate co-occupancy of Oct4 and Otx2 using re-ChIP analysis
by first precipitating Otx2 and then performing sequential ChIP
with Oct4 antibodies (Figure 1E) but were unable to detect inter-
actions between Otx2 and Oct4 in coimmunoprecipitation
assays.
Gene ontology analysis revealed that Otx2+/Oct4+ regions are
associated with genes involved in various developmental pro-
cesses including primary neural tube formation, consistent with
previous known functions of Otx2 in the development of the ner-
vous system (Figure 1F). However, other commonly overrepre-
sented terms include stem cell differentiation/development
consistent with a role in fate transition from ground state plurip-
otency. In contrast, Otx2+/Oct4 regions are associated with
different GO terms, many of which contain genes that cause
negative regulation of signaling pathways and gene activation
(Figure 1F). Thus, we have defined two types of Otx2 binding
region depending on whether Oct4 cobinding occurs and these
two different categories of binding region are associated with
genes involved in different biological processes.
Oct4 Controls Otx2 Levels
Having established that Otx2 and Oct4 potentially coregulate a
large number of genes during exit from pluripotency, we next
askedwhether they influenced each other’s expression to create
a regulatory switch. Otx2 expression at the protein and mRNA
levels is rapidly induced over 12 hr as mESCs escape from
ground state pluripotency following removal of 2i, whereas
Oct4 levels remain relatively stable over the same period (Figures
2A and 2B). Otx2 levels peak at 1 day, and then both Otx2 and
Oct4 levels subsequently decrease over an extended period of
5 days (Figures 2C and 2D). These temporal expression patterns
suggest that Oct4 might act upstream of Otx2 to control its
expression. Indeed depletion of Oct4 resulted in reduced Otx2
mRNA and protein levels, whereas Otx2 depletion had no effect
on Oct4 expression (Figures 2E, 2F, S2A, and S2B). In contrast,
none of the other pluripotency-associated transcription factors
we tested affected Otx2 expression (Figures S2C–S2H), demon-
strating the specificity of this effect. Inspection of our ChIP data
suggest that the regulatory effect ofOct4might bedirect because
Oct4 binding is detected at an enhancer region close to theOtx2
locus, and this region shows evidence of increased H3K27 acet-
ylation as the Otx2 locus becomes activated (Figure S2I).
To attempt to circumvent this regulatory effect of Oct4, we
created a mESC line (Otx2/dox-2) harboring a doxycycline-
inducible Otx2 transgene. However, although Otx2mRNA levels
were rescued by ectopic Otx2 expression following Oct4 deple-
tion (Figure S2J), incomplete rescue was observed at the protein
level (Figure 2G; compare lanes 4 and 6). This suggested that
Oct4 might also be required for Otx2 protein stability. Indeed, in-
clusion of the proteasome inhibitors, MG132 or lactacystin
restored Otx2 protein to levels observed upon release from 2i
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(Figure 2G, lanes 7–9) whereas Oct4 levels were unaffected (Fig-
ure S2K). Altogether, these results demonstrate that Oct4 is
required for Otx2 transcription and also contributes to stabilizing
Otx2 at the protein level (Figure 2H).
Otx2+/Oct4 and Otx2+/Oct4+ Binding Regions Exhibit
Different Functional Properties
Next, we investigated whether there are any potential functional
and regulatory differences between regions occupied by Otx2
alone (Otx2+/Oct4) or in combination with Oct4 (Otx2+/Oct4+).
First, we examined the genomic distributions of the two types of
binding region. In both cases, the vast majority of binding peaks
are associated with intergenic and intronic regions, suggestive
of enhancer activity, although significantly more Otx2+/Oct4
peaks are associated with promoter regions (Figure 3A). Both
Otx2+/Oct4 and Otx2+/Oct4+ binding regions show increased
occupancy by Otx2 over 12 hr following release from 2i, but the
Otx2+/Oct4+ binding regions exhibit more rapid occupancy that
begins to plateau at 8 hr (Figures 3B and S3A). Furthermore,
FAIRE-seq analysis demonstrates that both types of binding
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Figure 1. Otx2 and Oct4 Bind to Similar Regulatory Regions
(A) Heatmap of tag densities of Otx2 binding over 12 hr following exit from pluripotency (2i). In each heatmap, the Otx2 tag density at that time point (indicated in
red) is plotted for 5 kb on either side of its binding peak summit, and the Otx2 tag densities at other time points are plotted on top of these summit coordinates. The
most significant de novomotifs discovered in the Otx2 binding regions at each of the time points are shown above the heatmaps, and the consensus Otx2 binding
motif is shown below.
(B) De novo motif discovery identifies an enriched motif in the Otx2 binding regions (top) that resembles the Oct4 consensus site (bottom).
(C) Heatmap of normalized Otx2 and Oct4 tag densities at the indicated times following exit from pluripotency (2i), plotted onto 4 kb regions centered on
the Otx2 peak summits at 12 hr. Data are partitioned based on whether there is co-occurrence of Otx2 and Oct4 binding (Otx2+/Oct4+) or Otx2 binding alone
(Otx2+/Oct4).
(D) Average tag density profiles of Otx2 and Oct4 ChIP-seq analyses mapped onto Oct4 binding region summits.
(E) Re-ChIP analysis of Otx2 (first ChIP) and Oct4 (second ChIP) at the indicated loci in the presence of 2i (+) or upon release for 12 hr (). Data are presented as
means ± SEM (n = 2).
(F) Gene ontology terms enriched among the genes associated with either the Otx2+/Oct4+ or the Otx2+/Oct4 binding regions. Data are shown graphically
according to their p values (x axis) and the associated category (y axis).
See also Figure S1.
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region exhibit increased chromatin opening, which also occurs
more rapidly in the Otx2+/Oct4+ group (Figures 3C and S3A).
These results suggest more rapid establishment of open Otx2-
bound enhancer regions in the Otx2+/Oct4+ data set potentially
due to the presence of initial Oct4 occupancy. To provide more
evidence for enhancer-like properties, we examined H3K4me1
(a general enhancer mark) and H3K27Ac (indicative of active en-
hancers) around Otx2 binding regions. Both histone marks were
found in the nucleosomal regions surrounding the Otx2 binding
peaks (Figures 3D and 3E). In mESCs maintained in 2i, higher
H3K27Ac levels were observed at regions that become bound
by both Otx2 and Oct4 (Otx2+/Oct4+) than those eventually
bound by Otx2 alone (Figure 3D), suggesting that these regions
represented active enhancers in the ground state. Consistent
with this idea, little change in H3K27Ac levels was observed
around the Otx2+/Oct4+ binding regions (Figure 3D), but in
contrast, enhanced H3K27Ac was observed in the Otx2+/
Oct4 binding regions as cells exited from pluripotency. This in-
crease in acetylation is indicative of enhancer activation and this
effect is even more dramatic when the Otx2+/Oct4 subcate-
gory is divided in two based on fold changes in H3K27Ac levels,
indicating that there is a large subset of enhancers that shows
big increases in H3K27Ac, consistent with their activation, and
another subset that changesminimally (Figure S3B). Importantly,
the increase in H3K27Ac at Otx2-bound enhancers was not due
to a generic effect because no global increases in this acetylation
event are observed around Oct4-bound regions or other
genomic regions (Figures S3C and S3D). H3K4me1 levels were
initially higher in Otx2+/Oct4+ binding regions but in contrast
to the differential effects seen with H3K27Ac, both Otx2+/
Oct4+ and Otx2+/Oct4 binding regions showed an increase
in H3K4me1 upon exit from ground state pluripotency (Fig-
ure 3E). Together, these results indicate that Otx2 binding corre-
lates with the acquisition of enhancer-like properties, and that de
novo enhancer activation occurs preferentially at regions where
Otx2 binds in the absence of coassociated Oct4.
Next, to examine a potential contribution of Oct4 in enhancer
activation, we further partitioned the Otx2+/Oct4+ binding re-
gions into those which exhibited increased Oct4 binding (Oct4
up) or no change/decreased Oct4 binding (Oct4 down) 16 hr
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Figure 2. Interplay between Oct4 and Otx2 Expression
(A and C) qRT-PCR analysis of Otx2 and Oct4 (also known as Pou5f1 but referred to here as Oct4 for clarity) mRNA expression in mouse ESCs (Rex1GFPd2)
during the indicated time courses following ‘‘2i’’ withdrawal. Data are normalized by the geometric mean of two reference genes (Ppia and Gapdh) and are
presented as means ± SEM and are the average of at least three biological replicates (nR 3).
(B and D) Immunoblots showing Otx2 and Oct4 levels during the indicated time courses of ‘‘2i’’ withdrawal. Dotted lines in (D, upper) indicate where gels have
been cut to remove irrelevant lanes and rejoined. Quantification of the data from (D) is shown below and are normalized for Erk2 levels and presented as means ±
SEM (n = 3).
(E and F) The expression of Otx2 and Oct4 was analyzed after knockdown of Otx2, Oct4 or in the presence of a nontargeting control siRNA (ctrl) at the indicated
times following ‘‘2i’’ withdrawal by qRT-PCR (E) or western blotting (F).
(G)Western blot of Otx2 andOct4 levels in wild-type (Rex1GFPd2)mESCs and a clonally derived cell line containing a doxycyclin-inducibleOtx2 transgene (Otx2/
dox-2). Cells are released of, from ‘‘2i’’ for 12 hr. Oct4 depletion (oct4i), the presence (+) or absence () of doxycycline (dox) and the proteasome inhibitors,
lactacystin and MG132, are indicated. Quantification is shown on the right and is normalized for Erk2 levels and presented as means ± SEM (n = 2).
(H) Model illustrating the impact of Oct4 on Otx2 expression at the RNA and protein levels.
See also Figure S2.
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Figure 3. Differential Properties of Otx2+/Oct4 and Otx2+/Oct4+ Binding Regions
(A) Distribution of Otx2 ChIP-seq regions relative to the indicated genomic features. Otx2 binding regions are partitioned into Oct4 (left) and Oct4+ (right)
subgroups. The promoter-specific association of Otx2+/Oct4 subgroups is statistically significant (p < 0.01).
(B and C) The average normalized tag densities from Otx2 ChIP-seq (B) or FAIRE-seq (C) analyses (y axes) associated with the summit of Otx2 binding regions
from the Otx2+/Oct4 and Otx2+/Oct4+ subgroups are shown for the indicated times following ‘‘2i’’ withdrawal (x axes).
(D and E) Average tag density profiles of H3K27Ac- (D) and H3K4me1-ChIP-seq (E) analyses mapped onto Otx2 binding region summits in the presence of 2i or
following 2i withdrawal for 12 hr. The Otx2 peaks are partitioned into Oct4 (left) and Oct4+ (middle) categories. The right images show the average normalized
tag densities of K3K27Ac (D) and H3K4me1 (E) ChIP-seq data (y axis) associated with the summit of Otx2 binding regions from the Otx2+/Oct4 and Otx2+/
Oct4+ subgroups for the indicated times following ‘‘2i’’ withdrawal (x axis).
(F and H) Heatmaps of Otx2 and Oct4 ChIP-seq tag densities in the 4 kb regions surrounding the summit of Otx2 binding regions at the indicated times following
exit from pluripotency (2i). Data are partitioned into regions showing increased (up; F) or decreased (down; H) binding of Oct4 at 16 hr after 2i withdrawal.
(G and I) Tag density profiles of H3K27Ac ChIP-seq data mapped onto the summits of Otx2 binding regions showing increased (G) or decreased (I) Oct4 binding
(see F and H) in the presence of 2i or following 2i withdrawal for 12 hr.
(J) Gene ontology terms enriched among the genes associated with either the Otx2+/Oct4+(up) or the Otx2+/Oct4+(down) binding regions. Data are shown
graphically according to their p values (x axis) and the associated functional category (y axis).
See also Figure S3.
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after release from 2i (Figures 3F, 3H, andS3E). The latter group
represents regions already occupied by Oct4 in 2i conditions.
Interestingly, enhanced H3K27Ac was observed in the Oct4
(up) group as cells exited from ground state pluripotency
whereas little changewas seen in theOct4 (down) group (Figures
3G and 3I). As observed with the Otx2+/Oct4 group, further
partitioning of the Otx2+/Oct4+(up) subcategory on the basis
of fold changes in H3K27Ac levels, indicating that there are large
subset of enhancers which show big increases in H3K27Ac,
consistent with their activation and another subset that changes
minimally (Figure S3F). Furthermore, increased FAIRE-seq signal
and H3K4me1 was observed in the Oct4 (up) group whereas
relatively little change was seen in the Oct4 (down) group (Fig-
ure S3G). Thus, where Otx2 binding coincides with enhanced
Oct4 binding, the binding of Otx2 correlates with the acquisition
of marks associated with active enhancers (i.e., de novo
enhancer formation), whereas pre-existing Oct4 binding corre-
lates with the retention of active enhancer marks (i.e., enhancer
maintenance). To examine whether these two types of enhancer
regions are associated with genes involved in distinct biological
processes, we performed gene ontology analysis on genes
associated with the Otx2+/Oct4+(up) and Otx2+/Oct4+(down)
subcategories. A clear distinction in GO terms was observed
with enhanced Oct4 binding being associated with the Wnt
signaling pathway and neuronal development, whereas regions
where Oct4 binding is either maintained or reduced are associ-
ated with stem cell maintenance and chromatin modification
(Figure 3J).
To establish whether Otx2 is required for enhancer activation,
we depleted Otx2 and examined H3K27Ac levels at candidate
loci representative of the Otx2+/Oct4+ and Otx2+/Oct4 bind-
ing regions. First, we investigated five loci where increases in
H3K27Ac were observed following release from 2i and in all
cases, these increases were reduced upon Otx2 depletion (Fig-
ure 4A). In contrast, at five other active enhancer regions where
high levels of H3K27Ac were initially observed, no reductions in
BA
C
Figure 4. Otx2 Is Required for Enhanced H3K27Ac and Oct4 Cobinding at a Subset of Its Binding Regions
(A–C) ChIP-qPCR analysis of H3K27Ac levels (A), p300 binding (B), or Otx2 andOct4 binding (C) to genomic regions associatedwith the indicated genes inmouse
ESCs. Cells weremaintained in 2i or cultured in the absence of 2i for 12 hr in the presence of siRNAs against Otx2 or control duplexes. Data in (A) are presented as
a heatmap (left) or bar chart (right) and depict the fold change in H3K27Ac levels following release from culture in 2i in the presence or absence of siRNAs against
Otx2. Data are presented as means ± SEM (n = 3 or n = 2 [indicated by *] in A and C and n = 2 in B).
See also Figure S4.
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acetylation levels were observed following Otx2 depletion (Fig-
ure 4A). In all cases, Otx2 depletion caused a reduction in Otx2
ChIP signal as expected (Figures 4C and S4A–S4C). H3K27Ac
is deposited by the p300 histone acetyltransferase (Pasini
et al., 2010b). We detected p300 in Otx2 immunoprecipitates
with mass spectrometry in four of five experiments (data not
shown). We therefore asked whether Otx2 is required for p300
recruitment. Enhanced p300 binding is observed upon 2i with-
drawal at regions exhibiting increased H3K27Ac levels such as
the Plekha1 and Myrf loci but is unaffected at regions where
acetylation levels remain stable (eg Foxd1 locus; Figure 4B).
However, upon depletion of Otx2, reductions in p300 binding
were seen at all loci where inducible p300 binding was observed
(e.g., Plekha1 andMyrf loci) but little effect was seen where p300
binding was stably maintained. Thus, Otx2 is required for the
inducible recruitment of p300.
Next we examined whether Otx2might also be required for the
increased Oct4 binding observed at the Otx2+/Oct4+(up) re-
gions. Consistent with this hypothesis, depletion of Otx2
reduced the Oct4 levels associated with several enhancer re-
gions including those associated Myrf and Slc16a3 loci (Fig-
ure 4C). In contrast, the Oct4 ChIP signal at regions exhibiting
little Oct4 binding or preassociated Oct4 in the ground state
such as the Foxd3 and Dnmt3a loci (Figures 4C and S4B),
were unaffected by Otx2 depletion.
Collectively, these data are consistent with a model whereby
Otx2 associates with enhancer regions and at a subset of these
is required for Oct4 binding and enhancer activation by p300
recruitment as mESCs transition from ground state pluripotency.
Coregulation of Target Gene Expression by Otx2
and Oct4
Having established that Otx2 and Oct4 commonly occupy many
enhancer regions and that Otx2 contributes to their activation,
we next wished to determine the regulatory outcomes in terms
of target gene expression. First, we performed microarray and
RNA sequencing (RNA-seq) analysis on mESCs treated with
siRNAs against Otx2 or control duplexes, and then either main-
tained them in the pluripotent ground state or allowed them to
exit by 2i withdrawal for 12 hr. More than 4,500 genes changed
their expression over this period (Figure S5A). Importantly,
> 500 genes were either up- or downregulated following Otx2
depletion 12 hr after release from 2i, and 10% of these genes
are potential direct targets because they are associated with
Otx2 binding regions (Figure 5A). Consistent with a role in exit
from pluripotency, genes that were upregulated upon release
from 2i, were predominantly downregulated by Otx2 depletion
(ie activated by Otx2) and the reciprocal observed for genes
that were downregulated upon release from 2i (Figures 5B and
S5B). Next, we examined whether the Otx2 regulated genes
are also potentially coregulated by Oct4 by comparing the
Otx2 depletion data with RNA-seq data from mESCs depleted
for Oct4 and released from ground state pluripotency. A statisti-
cally significant overlap was observed between genes either
activated or repressed by both Otx2 and Oct4 (Figure 5C) and
this association was maintained when the data were partitioned
to examine their effects on genes whose expression changed
during exit from pluripotency such as Slc16a3 (Figures S5C
and 5D). To further substantiate these results, we examined
the expression of a panel of genes over 24 hr following 2i
withdrawal in the presence or absence of either Otx2 or Oct4
depletion. Genes exhibited expression profiles consistent with
our RNA-seq analysis (Figures 5E, 5F, and S5D–S5G). Fifteen
different direct Otx2 target genes exhibited robust upregulation
following exit from pluripotency, and this increase was damp-
ened upon Otx2 depletion and even more so by Oct4 depletion
(Figures 5E, 5F, and S5D). These results are consistent with
a coregulatory effect of Otx2 and Oct4 on gene expression.
However, this was not a generic effect because other genes
where Otx2 loss reduces their expression exhibited upregulation
upon Oct4 depletion and vice versa, suggesting alternative roles
for Otx2 and Oct4 in these contexts (Figures S5E–S5G).
Our GO term analysis indicated that genes in the ‘‘primary neu-
ral tube formation’’ category constituted one of the most signif-
icant terms associated with Otx2+/Oct4+ binding regions (Fig-
ure 3J). This was of interest because Otx2 has previously been
implicated in controlling various aspects of neuronal differentia-
tion (reviewed in Beby and Lamonerie, 2013). We therefore
examined whether Otx2 might play a role in regulating the
expression of these genes at this very early time point in the dif-
ferentiation process. Interestingly, six of the Otx2 target genes in
this category exhibited upregulation upon exit from the ESC
state, and Otx2 depletion reduced the activation of three of
these, Apaf1, Enah, and Tgif1 (Figure 5G). These three genes
also exhibit evidence of increased coassociated H3K27Ac and
hence enhancer activation (e.g., Enah; Figure 5G, right). Thus,
Otx2 is implicated in specifying subsequent developmental pro-
cesses at a very early stage.
Next, we askedwhether the changeswe observed in enhancer
activation correlated more generally with Otx2-mediated gene
activation, and examined the changes in histone marks and
chromatin structure at enhancer regions associated with genes
showing upregulation during transition from naive pluripotency
and dependency on Otx2 presence. Low initial levels of
H3K27Ac were observed at enhancers bound by Otx2 alone
(Otx2+/Oct4), which subsequently increased as cells exited
from pluripotency and is indicative of enhancer activation (Fig-
ures 6A and S6A). This is illustrated clearly in regions associated
with theHells andDnmt3a loci (Figures 6C and 6E). This increase
was not apparent at Otx2+/Oct4+ regions. However, increased
levels of H3K4Me1 and FAIRE-seq signal were observed at
both Otx2+/Oct4+ and Otx2+/Oct4 regions, suggestive of de
novo enhancer production (Figure S6A). This wasmore apparent
for the regions bound by Otx2 alone. When the Otx2+/Oct4+ re-
gions were further partitioned according to either enhanced or
decreased/no change in Oct4 binding upon exit from pluripo-
tency, increased H3K27Ac was preferentially observed at en-
hancers exhibiting enhanced Oct4 binding (Otx2+/Oct4+ up;
Figure 6B) such as the Myrf locus (Figure 6D) rather than where
Oct4 binding is maintained (e.g., Dnmt3a locus; Figure 6E).
These changes are indicative of enhancer activation, but only
moderate increases in H3K4Me1 levels were observed (Fig-
ure S6B), suggesting that this represents activation of pre-estab-
lished poised enhancers.
Collectively, these data therefore demonstrate that Otx2 is
required for enhancer activation and associated target gene
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activation, and at a subset of these regions promotes the same
regulatory events through stimulating Oct4 recruitment.
Otx2 Drives Enhances Activation, Oct4 Recruitment,
and Target Gene Expression
To establish whether Otx2 plays a causative role in activating
enhancers and associated gene expression, we induced Otx2
from a doxycycline-regulated expression cassette in cells
maintained in the pluripotent ground state through culturing in
2i and asked if this was sufficient to drive downstream regula-
tory events. Importantly, we obtained Otx2 expression levels
that are similar to those observed after 2i withdrawal (Figures
S7A and S7B). First, we tested whether Otx2 could drive
gene expression changes by testing a panel of its target genes.
We were able to demonstrate that Otx2 was able to drive the
expression of a large number of its target genes, despite the
cells being held in the pluripotent state (Figure 7A). Importantly,
this effect was largely limited to those genes identified as
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Figure 5. Otx2 and Oct4 Coregulate Target Gene Expression
(A) Volcano plot of microarray data showing gene expression changes in mESCs (Rex1GFPd2) cells 12 hr after ‘‘2i’’ withdrawal following Otx2 depletion or
treatment with control siRNAs (top). The table depicts the intersection between expression microarray and Otx2 ChIP-seq data sets (bottom).
(B) Pie charts showing the proportion of genes up or downregulated uponwithdrawal of 2i from ESCs for 12 hr, for subcategories of genes that are either activated
(top) or repressed (bottom) by Otx2.
(C) Summary of gene expression changes affected by Otx2 and Oct4 depletion observed 12 hr after 2i release. p Values are calculated from a hypergeometric
distribution.
(D) UCSC genome browser view of Otx2 binding profiles and RNA-seq tags associated with the Slc16a3 locus. Data are shown for the indicated times following
release from 2i and for the RNA-seq data, treatment with control (ctrl) or the indicated RNAi (i) duplexes. RPKM values for each time point are shown on the right.
(E and F) Heatmap (E) and selected examples (F) of qRT-PCR analysis with the Fluidigm system ofmRNA expression of the indicated genes over 24 hr following 2i
withdrawal. Cells were treated with control,Otx2, orOct4 siRNAs where indicated. Data in (E) are row Z score normalized and are presented in (F) as means ± SD
(nR 3). Genes associated with Oct4 binding regions are indicated by purple dots.
(G) Expression analysis of the genes in the ‘‘primary neural tube formation’’ gene ontology category that are direct targets of Otx2 and Oct4, either in 2i conditions
or upon withdrawal from 2i for 12 hr in the presence of control (ctrl) or Otx2 siRNAs. Data are from RNA-seq analysis and are shown as a heatmap (row Z-
normalized; left) and the individual profiles of the top six genes in the heatmap are shown graphically (middle). A UCSC genome browser view of the ChIP profiles
across the Enah locus is shown on the right.
See also Figure S5.
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activated by Otx2 through our siRNA analysis (Figure 7A; genes
bracketed by red bar). Otx2-driven transcription was observed
on targets belonging to the Otx2+/Oct4 (Figure 7B) and the
Otx2+/Oct4+ categories (Figures 7D and 7F). This was not a
generic effect because Otx2 expression had little effect on
other control genes and other Otx2 binding targets whose
expression was not Otx2-dependent under normal differentia-
tion conditions (Figures 7A and S7C). The levels of target
gene expression were variable and did not attain the levels
seen during exit from ground state pluripotency; however,
this is not surprising given the fact that Otx2 likely collaborates
with many other additional factors during ESC differentiation.
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Figure 6. Enhancer Activation Correlates with Otx2 Target Gene Activation
(A and B) Average tag density profiles showing indicated ChIP-seq data mapped onto the 2 or 4 kb regions surrounding the summits of Otx2 binding regions
associated with Otx2 activated genes and from the Otx2+/Oct4 and Otx2+/Oct4+ subgroups (A) or associated with Otx2 binding regions showing increased
(up) or decreased/no change (down) in Oct4 binding in the presence of 2i or for the indicated times following 2i withdrawal (B). Numbers in brackets represent the
number of binding regions in each subgroup.
(C–E) UCSC genome browser views of Otx2, Oct4, and H3K27Ac binding profiles and RNA-seq signals associated with the Hells (C), Zfp42 (D), and Dnmt3a (E)
loci. Otx2 binding regions are boxed. RPKM values for the RNA-seq data are shown adjacent to the relevant lanes.
See also Figure S6.
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Next, we examined whether Otx2 expression was sufficient to
activate the enhancer regions associated with its regulated
genes, and hence provide a more direct link between enhancer
activation and transcriptional upregulation. First we tested bind-
ing regions where Otx2 either bound independently from Oct4
(Otx2+/Oct4) or where it was required for Oct4 binding
(Otx2+/Oct4+[up]) because these regions showed the character-
istic of enhanced H3K27Ac during exit from ground state plurip-
otency (Figure 3). All of the tested regions showed evidence of
Otx2-driven increases in K3K27Ac (Figures 7C and 7E). Howev-
er, Otx2 was unable to drive increases in H3K27Ac at regions
from theOtx2+/Oct4+(down), whichwe demonstrated to contain
preactive enhancers whose H3K27Ac levels do not change dur-
ing differentiation (Figure 7G). Moreover, we also tested Oct4
occupancy at the same loci and demonstrated that Otx2 is suf-
ficient to drive enhanced Oct4 occupancy but only at regions
from the Otx2+/Oct4+(up) category (Figures 7C, 7E, and 7G),
which we demonstrated to exhibit Otx2-dependent increased
Oct4 occupancy during normal differentiation (Figure 4C).
Together, these data demonstrate that Otx2 is sufficient to
drive enhancer activation, and associated gene expression,
and at a subset of regions, promotes Oct4 recruitment. Together
with our loss-of-function analysis, these data demonstrate
that Otx2 plays a significant role in driving these regulatory
processes.
DISCUSSION
Previous studies established that Otx2 plays an important role in
the early stage of ESC differentiation (Acampora et al., 2013).
Here we have revealed how Otx2 drives this process through
collaboration with Oct4 and enhancer activation. Otx2 binds to
hundreds of enhancer regions and these can be subcategorized
into three broad types (Figure 7H). First, there are enhancers
that are prebound by Oct4 in the ground state, show rapid
Otx2 binding, and possess active enhancer marks that do not
change upon Otx2 binding. This is consistent with a role in
enhancer maintenance. Second, there are enhancers that
show increased Otx2 occupancy, Otx2-dependent enhanced
Oct4 occupancy, and enhanced histone activation marks. Third,
there are enhancers that bind Otx2 in the absence of detectable
Oct4 binding and are also characterized by increases in ‘‘active’’
chromatin marks. Importantly, the latter two types of enhancers
exhibit Otx2-dependent activation marks but show slower Otx2
occupancy consistent with a role for prebound Oct4 in promot-
ing more rapid Otx2 recruitment. At the apparent ‘‘Oct4’’-inde-
pendent sites, it is likely that Otx2 collaborates with as-yet un-
identified prebound transcription factors or additional proteins
that are induced as cells transition from pluripotency. Biologi-
cally, different enhancer subclasses are associated with genes
involved in distinct biological processes, demonstrating that
the mechanistic differences we uncover likely relate to distinct
downstream events in the differentiation process. For example,
enhancers bound by Otx2 in the absence of Oct4 are associated
with genes involved in negative regulation of signaling, suggest-
ing a role for Otx2 in rewiring the signaling networks as cells exit
ground state pluripotency. For example, target genes Dusp6
and Spry4 in the GO term category ‘‘negative regulation of
MAP kinase activity’’ might influence ERK pathway signaling,
which plays an important role as cells initiate differentiation
(Ying et al., 2008). Whereas Otx2 is involved in enhancer main-
tenance with Oct4, associated genes are involved in stem cell
maintenance and chromatin organization. In contrast, when
Otx2 and Oct4 come together to activate enhancers, the asso-
ciated genes are involved in neural development and Wnt
pathway signaling. This is consistent with the known role of
Otx2 in neural development (Beby and Lamonerie, 2013) and
suggests that this is initiated in collaboration with Oct4 at a
very early stage.
We previously identified Oct4 as a candidate determinant of
exit from ground state pluripotency (Yang et al., 2012). Here,
we demonstrate an important role for Oct4 in collaboration
with Otx2 in controlling the activity of genomic regulatory re-
gions during the early stages of exit from ground state pluripo-
tency. This complements other recent work that demonstrated
that artificial manipulation of Oct4 levels can influence reprog-
ramming and exit from pluripotency (Radzisheuskaya et al.,
2013). Oct4 has been proposed to be important for promoting
mesendodermal differentiation (Thomson et al., 2011) and part
of this mechanism might be explained by switching binding
partners from Sox2 to Sox17 (Aksoy et al., 2013). It is not clear
whether partner switching occurs with an Otx2-related protein
and this remains a possibility, but the de novo recruitment of
Oct4 in an Otx2-dependent manner suggests the formation of
new regulatory complexes, at least a subset of enhancers. It
remains unclear as to how Otx2 promotes Oct4 recruitment
because we have been unable to detect protein-protein inter-
actions and no composite binding motifs are apparent. This
suggests a more indirect recruitment mechanism, perhaps
through enhancer opening and activation, because we gener-
ally find Otx2-dependent H3K27Ac coincident with enhanced
Oct4 binding. It also remains possible that Oct4 recruitment
contributes to these increases in enhancer activation. However,
further studies are required to uncover the critical molecular
events required for promoting Oct4 binding and its potential
role in enhancer activation. We were unable to detect any other
strongly over-represented binding motifs in the Otx2-bound
regions that lacked Oct4 binding, suggesting that this is the
most common combinatorial binding mode used by Otx2.
However, a small proportion of regions contained Nanog bind-
ing motifs (Figure S1D), although co-occupancy appears un-
likely given their mutually exclusive expression profiles. It is
probable that Otx2 will collaborate with other heterologous
transcription factors to activate enhancers and drive target
gene activation. Indeed, this is likely to occur even at the
Otx2+/Oct4+ regulatory elements and will provide enhancer-
specific activities.
ESCs cultured in 2i conditions closely resemble the naive
epiblast of the preimplantation mouse embryo (Boroviak et al.,
2014). Transition from this ground state proceeds in a defined
in vitro differentiation protocol upon simple withdrawal of the 2i
inhibitors and consequent activation of the MEK/ERK pathway
and GSK3 ensues. Oct4 expression remains relatively constant
whereas Otx2 is robustly induced. This mirrors formation of the
egg cylinder in the postimplantation embryo (Acampora et al.,
2013). Indeed, it has recently been shown that Otx2 is required
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Figure 7. Otx2 Drives Enhancer Activation, Oct4 Recruitment, and Target Gene Expression
(A–G) Heatmap (A) and selected examples (B, D, and F) of qRT-PCR analysis with the Fluidigm system of mRNA expression of the indicated genes in wild-type
(Rex1GFPd2), mESCs and two clonally derived cell lines, Otx2/dox-1 and Otx2/dox-2, containing a doxycyclin-inducible Otx2 transgene. Cells were maintained
in 2i media and either left untreated or treated with increasing concentrations (10 and 100 ng/ml) of doxycycline (dox) for 24 hr. Data in (A) are row Z score
normalized and are presented in (B, D, and F) as means ± SEM (n = 3). The vertical color bars represent the following categories of genes based on siRNA
depletion experiments; Otx2 upregulated (red), Otx2 downregulated (blue), control nontargets (green), and not regulated by Otx2 (gray). Gene expression
following release from 2i for 12 hr is also shown in (B, D, and F). ChIP-qPCR analysis of H3K27Ac levels or Otx2 and Oct4 binding to genomic regions associated
(legend continued on next page)
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for efficient differentiation of ESCs in vitro and conversely that
loss of Otx2 destabilizes the differentiated state. Our results
therefore provide mechanistic insight into underlying this cell-
fate transition.
In summary, we have identified Otx2 as a key player in driving
the establishment of a gene regulatory landscape as mESCs
transition from ground state pluripotency. Future studies will
determine themolecularmechanisms that enable Otx2 and other
factors to create this environment.
EXPERIMENTAL PROCEDURES
Tissue Culture, RNA Interference, and RT-PCR
Mouse Rex1GFPd2 ESCs and the Otx2/dox1-3 derivatives (containing a
doxycycline-inducible transgene; see the Supplemental Experimental Proce-
dures for more details) were maintained as described previously in NDiff
N2B27 media containing 2i inhibitors (CHIR99021 and PD0325901; Yang
et al., 2012). Where indicated, cells were treated with the proteosome inhibi-
tors, MG132 (1 mM) and clasto-lactacystin-b-lactone (1 and 10 mM), and doxy-
cycline (100 ng/ml). RNAi was performed as described previously (Yang et al.,
2012)
Real time qRT-PCRwas carried out as described previously (O’Donnell et al.
2008). Data were normalized for the geometric mean expression of the control
genes gapdh and ppia. Expression analysis using the Fluidigm BioMark HD
system was performed according to the manufacturer’s protocols. In brief,
RNA samples were reverse-transcribed into cDNA using Superscript III (Invi-
trogen). Specific target amplification using primers for the genes to be
analyzed was performed to increase the number of copies of target cDNA,
before analysis on the Fluidigm system. Prior to qPCR reactions, the specific
target amplification reaction was treated with exonuclease I to eliminate the
carryover of unincorporated primers. The primer-pairs used for RT-PCR are
listed in Table S1.
Western Blot Analysis
Western blotting was carried out with the primary antibodies; Erk2 (137F5; Cell
Signaling Technology, 4695), Otx2 (ProteinTech, 13497-1-AP), and Oct4 (Oct-
3/4; Santa Cruz Biotechnology, sc-8628). All experiments were carried out in
12-well plates. The lysates were directly harvested in 23 SDS sample buffer
(100 mM TrisCl [pH 6.8], 4% SDS, 20% glycerol, 200 mM dithiothreitol, and
0.2% bromophenol blue) followed by sonication (Bioruptor, Diagenode). The
proteins were detected using a LI-COR Odyssey Infrared Imager as described
previously (Yang et al., 2012).
ChIP Assays
ChIP assays using Otx2 (ProteinTech., 13497-1-AP), Oct4 (Oct-3/4; Santa
Cruz, sc-8628), p300 (Upstate, 05-257), H3K27Ac (Abcam, ab8895), and
H3K4me1 (Abcam, ab4729) were performed essentially as described previ-
ously (Lee et al. 2006) with 1 mg antibodies and 13 106 ESCs for a transcription
factor ChIP and 2.5 mg antibodies and 0.2 3 106 ESCs for a histone ChIP.
Bound regions were detected by quantitative PCR with the Fluidigm system.
Prior to loading onto the BioMark HD platform (Fluidigm), ChIP samples
were preamplified for 10 cycles with 23 TaqMan PreAmp Master Mix (Applied
BioSystems).
For re-ChIP assays, 3 3 106 cells were used with anti-Otx2 (first antibody)
at 4C overnight and continued as for the ChIP assay. After the 13 TE
wash, immunoprecipitated complexes were twice eluted gently in 15 ml
10 mM dithiothreitol for 30 min at 37C. Combined eluates were added
to 1 ml IP buffer and incubated with the anti-Oct4 (second antibody) over-
night at 4C.
ChIP-Seq, FAIRE-Seq, and RNA-Seq Assays
ChIP for ChIP-seq assays was performed as described above except that we
used 2.5 mg antibodies and 1.53 107 ESCs for a transcription factor ChIP and
10 mg antibodies and 0.75 3 107 ESCs for a histone ChIP. The ChIPed
and input DNA libraries were generated and sequencing was performed on
an Illumina GAIIx or Hi-seq genome analyzer according to the manufacturer’s
protocols. FAIRE-seq assays were essentially performed as described previ-
ously (Simon et al. 2012) with 2 3 106 ESCs per condition. Libraries for
RNA-seq were generated with a SENSE mRNA-seq library kit (Lexogen) and
sequencing was performed on an Illumina GAIIx genome analyzer according
to the manufacturer’s protocols.
Expression Microarray Analysis
mRNA was isolated and the labeling and expression profiling using Affymetrix
arrays (genechip mouse genome 430 2.0 array) was performed as described
previously (Boros et al. 2009). Duplicate experiments were performed in
each condition.
Bioinformatics and Statistical Analysis
All software was run in default settings unless otherwise indicated. Se-
quences from the ChIP-seq (using 36 bp for Otx2, 50 bp for H3K4me1 and
H3K27Ac), FAIRE-seq (using 100 bp), and RNA-seq (using 100 bp) were
aligned against National Center for Biotechnology Information build 37/
mm9 of mouse genome using Bowtie (Langmead et al. 2009), allowing up
to two mismatches. Only reads that were uniquely mapped to the genome
were preserved. The reads mapped to the mitochondrial genome were
removed.
For ChIP-seq experiments, ChIP data were compared to input chromatin
and peaks were called by MACS (version 1.4.1; Zhang et al. 2008) and Homer
software (version 4.1; Heinz et al. 2010). The intersection (1 bp overlap) of
called peaks was subsequently annotated using bedTools (version 2.17.0;
Quinlan and Hall, 2010). Only peaks identified in both peak callers were re-
tained for the further analysis. Motif discovery and the significance of discov-
ered motifs was performed by Homer with the sequences within ± 100 bp
around the binding region summits, with the default background setting; i.e.,
sequences randomly selected from the genome with the same GC content
as the target sequences.
Nearest genes were assigned to peaks by Homer software and GREAT
(McLean et al. 2010). For the gene ontology analyses, nearest genes were as-
signed byGREAT. For the expression analysis, geneswere initially assigned by
both Homer and GREAT. Due to the ambiguity of the annotation, the changes
in gene expression upon Otx2 depletion were also considered in selecting the
most likely of multiple options of gene-peak assignment. Genomic distribu-
tions were determined using Homer.
The peak overlaps between Otx2 and Oct4 ChIP-seq data sets were carried
out with bedTools with a setting that at least 10%of reciprocal peaks intersect.
The normalized tag density profiles were generated using annotatePeak.pl
(Homer) and were plotted using Excel. Heatmaps of ChIP-seq data set were
generated with Java treeview (Eisen et al. 1998) and heatmaps of expression
data were generated by Multiexperiment Viewer (MeV 4_7_4; Saeed et al.
2003). For constructing networks, lists of gene names were uploaded into in-
genuity pathway analysis software (Ingenuity Systems).
For microarray analysis, data were normalized with RMA and analyzed by
limma (Partek Genomics Suite, Bioconductor; Smyth, 2004). Genes were
taken as significantly up or downregulated with an expression change of at
least 1.2-fold and a p value < 0.05. For RNA-seq analysis, data were analyzed
using TopHat and Cufflinks as described previously (Trapnell et al., 2012) and
genes were taken as significantly up or downregulated with an expression
change (RPKM) of at least 1.5-fold.
The significance of overlaps between expression array and ChIP-seq data
sets was calculated as described previously (Boros et al., 2009). The
with the indicated genes in Otx2/dox-3mESCs (C, E, andG). Cells weremaintained in 2i either in the presence or absence of doxycycline (dox) treatment for 24 hr.
Data are presented as means ± SEM (n = 3).
(H) Model illustrating the impact of Otx2 on enhancer activation during early stem cell commitment.
See also Figure S7.
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significance of differences between the genomic distributions of promoter-
associated Otx2 binding regions was calculated using a Pearson’s chi-square
test with Yates continuity correction, assuming an expected association of
1.1%.
ACCESSION NUMBERS
The ArrayExpress accession numbers for the microarray, RNA-seq, FAIRE-
seq, Otx2, H3K27Ac and H3K4me1, and Oct4 ChIP-seq data reported in
this paper are E-MTAB-2239, E-MTAB-2245, E-MTAB-2283, E-MTAB-2281
and E-MTAB-2282, and E-MTAB-2490, respectively.
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